Abiopharma

🔍 Lam Yat Tung (Director)

Company: Credo Technology Group Holding Ltd (CRDO)

Report Date: 2026-06-23

Detailed Transactions and Holdings:

• Sold 7,000 shares of Ordinary Shares (Direct)
  Date: 2026-06-23 | Code: G | equity_swap_involved: 0 | shares_owned_after: 2,646,969.00 | transaction_form_type: 4
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-23 | Code: H | nature_of_ownership: By EZ Trust | shares_owned_after: 125,000.00 | Footnotes: F1
• Holds 0 shares of Ordinary Shares (Direct)
  Date: 2026-06-23 | Code: H | nature_of_ownership: By Zhan BVI Co Ltd | shares_owned_after: 400,000.00 | Footnotes: F2

Footnotes:

• F1: The Reporting Person disclaims beneficial ownership except to the extent of his spouse's pecuniary interest therein.
• F2: The Reporting Person disclaims beneficial ownership of these indirectly held shares except to the extent of any pecuniary interest therein.